Michael Crick

Title: Michael Crick - Innovator in Metered Dose Inhalers

Introduction

Michael Crick is a notable inventor based in Glen Rock, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of metered dose inhalers. With a total of 3 patents to his name, Crick's work has had a substantial impact on the treatment of respiratory disorders.

Latest Patents

Among his latest patents, Crick has developed metered dose inhalers that utilize fluticasone or its pharmaceutically acceptable esters. These inhalers are designed to contain a stable pharmaceutical composition within a canister fitted with a metering valve, an actuator, and a dose counter. The invention also encompasses a process for preparing this pharmaceutical composition, which is intended for use in treating respiratory disorders such as asthma in patients.

Career Highlights

Michael Crick is currently associated with Glenmark Pharmaceuticals Limited, where he continues to innovate and contribute to the field of respiratory health. His expertise in pharmaceutical formulations has positioned him as a key player in the industry.

Collaborations

Crick has worked alongside talented colleagues, including Julianne Berry and Rajesh Ankam, who have contributed to his projects and innovations.

Conclusion

Michael Crick's work in developing metered dose inhalers represents a significant advancement in respiratory treatment options. His patents and ongoing contributions to Glenmark Pharmaceuticals Limited highlight his dedication to improving patient care.